Department of Internal Medicine and Liver Research Institute, College of Medicine, Seoul National University, Seoul, South Korea.
Division of Gastroenterology, Department of Internal Medicine and Liver Research Institute, College of Medicine, Seoul National University, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
J Gastrointest Surg. 2020 Jul;24(7):1499-1509. doi: 10.1007/s11605-019-04302-0. Epub 2019 Jul 16.
Although additive radical surgery is recommended for patients with non-curative endoscopic resection for early gastric cancer (EGC), lymph node (LN) metastasis or remnant tumor is detected in only about 10% of patients. Therefore, we aimed to identify patients who required surgery by identifying significant risk factors for LN metastasis and evaluate long-term outcomes in patients with non-curative endoscopic resection.
We retrospectively analyzed the database of Seoul National University Hospital to identify patients who underwent endoscopic resection for EGC from June 2005 to December 2016.
Three hundred and twenty-nine patients did not meet the criteria for curative resection after endoscopic resection. Among them, 140 patients underwent additional surgery and 171 patients refused surgery and regularly received follow-up. In the surgery group, LN metastasis was found in 12.1% of patients. Logistic regression analysis revealed that the rate of LN metastasis was significantly higher in patients with lymphatic invasion (LI) (odds ratio [OR] 5.84, p = 0.014) and venous invasion (VI) (OR 5.66, p = 0.006). We analyzed LN metastasis based on LI and VI in the surgical group. LN metastasis was significantly increased in the positive LI and VI groups compared with the negative LI and VI groups (OR 68.32; 95% confidence interval, 4.74-984.82; p = 0.002).
Both LI and VI were significant predictors of LN metastasis. The risk of LN metastasis was augmented when both LI and VI were positive. Therefore, LI and VI should be evaluated separately in patients with non-curative endoscopic resection. Additive surgery should be recommended for patients with LI and/or VI.
尽管对于内镜下切除非治愈性早期胃癌(EGC)的患者,推荐进行附加根治性手术,但只有约 10%的患者检测到淋巴结(LN)转移或残留肿瘤。因此,我们旨在通过确定 LN 转移的显著危险因素来识别需要手术的患者,并评估非治愈性内镜切除患者的长期结果。
我们回顾性分析了首尔国立大学医院的数据库,以确定 2005 年 6 月至 2016 年 12 月期间接受内镜下 EGC 切除术的患者。
329 例患者在内镜切除后不符合治愈性切除标准。其中,140 例患者接受了附加手术,171 例患者拒绝手术并定期接受随访。在手术组中,12.1%的患者发现 LN 转移。Logistic 回归分析显示,有淋巴管浸润(LI)(优势比[OR] 5.84,p=0.014)和静脉侵犯(VI)(OR 5.66,p=0.006)的患者 LN 转移率显著更高。我们在手术组中根据 LI 和 VI 分析了 LN 转移。与 LI 和 VI 阴性组相比,LI 和 VI 阳性组的 LN 转移明显增加(OR 68.32;95%置信区间,4.74-984.82;p=0.002)。
LI 和 VI 均为 LN 转移的显著预测因子。当 LI 和 VI 均为阳性时,LN 转移的风险会增加。因此,对于非治愈性内镜切除的患者,应分别评估 LI 和 VI。对于 LI 和/或 VI 的患者,应推荐附加手术。